Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Schizophrenia

  Free Subscription


Articles published in J Clin Psychopharmacol

Retrieve available abstracts of 102 articles:
HTML format



Single Articles


    May 2020
  1. YESILKAYA UH, Balcioglu YH
    Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia: Anti-obsessional Efficacy of Partial Agonism.
    J Clin Psychopharmacol. 2020 May 19. doi: 10.1097/JCP.0000000000001214.
    PubMed    


  2. BIRNBAUM R, Weinberger DR
    Special Article: Translational Science Update. Pharmacological Implications of Emerging Schizophrenia Genetics: Can the Bridge From 'Genomics' to 'Therapeutics' be Defined and Traversed?
    J Clin Psychopharmacol. 2020 May 18. doi: 10.1097/JCP.0000000000001215.
    PubMed     Abstract available


  3. FRIENDSHUH CR, Pocivavsek A, Demyonovich H, Rodriguez KM, et al
    The Effects of a Gluten-Free Diet on Immune Markers and Kynurenic Acid Pathway Metabolites in Patients With Schizophrenia Positive for Antigliadin Antibodies Immunoglobulin G.
    J Clin Psychopharmacol. 2020;40:317-319.
    PubMed    


  4. KUZIN M, Bochon B, Vagiaris E, Dammann G, et al
    Changes in Clozapine Bioavailability in a Percutaneous Endoscopic Gastrostomy-Fed Patient With Treatment-Resistant Schizophrenia.
    J Clin Psychopharmacol. 2020;40:306-308.
    PubMed    


  5. MELTZER HY, Share DB, Jayathilake K, Salomon RM, et al
    Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia.
    J Clin Psychopharmacol. 2020;40:240-249.
    PubMed     Abstract available


    March 2020
  6. GROVER S, Verma M, Chakrabarti S
    Safety of Use of Clozapine in Patients With Schizophrenia With Comorbid Diabetes Mellitus.
    J Clin Psychopharmacol. 2020 Mar 17. doi: 10.1097/JCP.0000000000001192.
    PubMed     Abstract available


  7. GLICK ID, Zamora D, Davis JM, Suryadevara U, et al
    Are Patients With Schizophrenia Better Off With Lifetime Antipsychotic Medication?: Replication of a Naturalistic, Long-Term, Follow-Up Study of Antipsychotic Treatment.
    J Clin Psychopharmacol. 2020;40:145-148.
    PubMed     Abstract available


  8. DANIEL NM, Maroney M
    Rates of Conversion From Substance-Associated Psychotic Disorder to Bipolar or Schizophrenia Spectrum Disorder in a Community-Based Teaching Hospital.
    J Clin Psychopharmacol. 2020;40:212-213.
    PubMed    


  9. DE DONATIS D, Porcelli S, Serretti A, Florio V, et al
    Serum Aripiprazole Concentrations Prehemodialysis and Posthemodialysis in a Schizophrenic Patient With Chronic Renal Failure: A Case Report.
    J Clin Psychopharmacol. 2020;40:200-202.
    PubMed    


  10. CORBEIL O, Corbeil S, Giroux I, Jacques C, et al
    Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients: A Series of 6 Case Reports.
    J Clin Psychopharmacol. 2020;40:191-194.
    PubMed     Abstract available


    December 2019
  11. SHADER RI
    In Addition to Pharmacotherapy and Psychotherapy for Psychosis, Is Anything Else Useful?
    J Clin Psychopharmacol. 2019 Dec 12. doi: 10.1097/JCP.0000000000001168.
    PubMed    


  12. HIRAPARA K, Munir A, Aggarwal R
    Hypothermia Associated With Paliperidone Depot Injection in Schizophrenia Patient: A Case Report.
    J Clin Psychopharmacol. 2019 Dec 10. doi: 10.1097/JCP.0000000000001155.
    PubMed    


  13. DESCALCO NFF, Afonso PMM
    Can Empathy Improve Therapeutic Adherence in Schizophrenia?
    J Clin Psychopharmacol. 2019 Dec 3. doi: 10.1097/JCP.0000000000001161.
    PubMed    


  14. CHAUHAN N, Chakrabarti S, Grover S
    Attitudes to Medication-Treatment Among Patients and Caregivers: A Longitudinal Comparison of Bipolar Disorder and Schizophrenia From India.
    J Clin Psychopharmacol. 2019 Dec 3. doi: 10.1097/JCP.0000000000001144.
    PubMed     Abstract available


    November 2019
  15. WALLING DP, Banerjee A, Dawra V, Boyer S, et al
    Phosphodiesterase 10A Inhibitor Monotherapy Is Not an Effective Treatment of Acute Schizophrenia.
    J Clin Psychopharmacol. 2019 Nov 1. doi: 10.1097/JCP.0000000000001128.
    PubMed     Abstract available


  16. VESELINOVIC T, Scharpenberg M, Heinze M, Cordes J, et al
    Dopamine D2 Receptor Occupancy Estimated From Plasma Concentrations of Four Different Antipsychotics and the Subjective Experience of Physical and Mental Well-Being in Schizophrenia: Results From the Randomized NeSSy Trial.
    J Clin Psychopharmacol. 2019 Nov 1. doi: 10.1097/JCP.0000000000001131.
    PubMed     Abstract available


    October 2019
  17. DEVRIMCI-OZGUVEN H, Atmaca M, Baran Z, Cengisiz C, et al
    Efficacy and Safety of Paliperidone Palmitate Treatment in Patients With Schizophrenia: A Real-World Multicenter, Retrospective, Mirror-Image Study.
    J Clin Psychopharmacol. 2019 Oct 29. doi: 10.1097/JCP.0000000000001133.
    PubMed     Abstract available


  18. SANAGAWA A, Shiraishi N, Sekiguchi F, Akechi T, et al
    Successful Use of Brexpiprazole for Parkinson's Disease Psychosis Without Adverse Effects: A Case Report.
    J Clin Psychopharmacol. 2019 Oct 29. doi: 10.1097/JCP.0000000000001127.
    PubMed    


  19. KORKMAZ H, Korkmaz S
    Hearts and Minds: Real-Life Cardiotoxicity With Clozapine in Psychosis.
    J Clin Psychopharmacol. 2019 Oct 29. doi: 10.1097/JCP.0000000000001117.
    PubMed    


  20. YEE JY, Lee TS, Lee J
    A Longitudinal Study of Serum Brain-Derived Neurotrophic Factor Levels in First-Episode Schizophrenia.
    J Clin Psychopharmacol. 2019 Oct 29. doi: 10.1097/JCP.0000000000001118.
    PubMed     Abstract available


  21. SHADER RI
    Psychosis and Psychotherapy.
    J Clin Psychopharmacol. 2019 Oct 28. doi: 10.1097/JCP.0000000000001134.
    PubMed    


  22. SABE M, Kirschner M, Kaiser S
    Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    J Clin Psychopharmacol. 2019 Oct 28. doi: 10.1097/JCP.0000000000001124.
    PubMed     Abstract available


  23. HASSANPOUR F, Zarghami M, Mouodi S, Moosazadeh M, et al
    Adjunctive Memantine Treatment of Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Study.
    J Clin Psychopharmacol. 2019 Oct 28. doi: 10.1097/JCP.0000000000001115.
    PubMed     Abstract available


  24. CITROME L, Ouyang J, Shi L, Meehan SR, et al
    Effect of Brexpiprazole on Agitation and Hostility in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies.
    J Clin Psychopharmacol. 2019 Oct 23. doi: 10.1097/JCP.0000000000001113.
    PubMed     Abstract available


    September 2019
  25. MIURA G, Misawa F, Kawade Y, Fujii Y, et al
    Long-Acting Injectables Versus Oral Antipsychotics: A Retrospective Bidirectional Mirror-Image Study.
    J Clin Psychopharmacol. 2019;39:441-445.
    PubMed     Abstract available


    August 2019
  26. CHEN SF, Shen YC
    Long-Acting Injectable Aripiprazole for a Schizophrenic Patient Concomitant With Stimulant Use Disorder.
    J Clin Psychopharmacol. 2019 Aug 19. doi: 10.1097/JCP.0000000000001087.
    PubMed    


  27. BAPTISTA A, Choucha W
    Dramatic and Rapid Resolution of Both Psychosis and Neuroleptic-Related Catatonia With Zolpidem in a Patient With Systemic Lupus Erythematosus.
    J Clin Psychopharmacol. 2019 Aug 19. doi: 10.1097/JCP.0000000000001088.
    PubMed    


    July 2019
  28. ANDORN A, Graham J, Csernansky J, Newcomer JW, et al
    Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia: Results From the Phase 3 Program.
    J Clin Psychopharmacol. 2019 Jul 23. doi: 10.1097/JCP.0000000000001076.
    PubMed     Abstract available


  29. NOEL MC, Powell V, Burton L, Panda R, et al
    Clozapine-Related Myocarditis and Rechallenge: A Case Series and Clinical Review.
    J Clin Psychopharmacol. 2019;39:380-385.
    PubMed     Abstract available


  30. ENGELKE C, Cordes J, Kahl KG, Schmidt-Kraepelin C, et al
    Attitudes Toward Long-Term Medication Use-A Comparison Between Concerned Populations and a Sample From the German General Population: An Example of Real World Evidence.
    J Clin Psychopharmacol. 2019;39:357-361.
    PubMed     Abstract available


    June 2019
  31. LACHANCE A, Corbeil O, Corbeil S, Chalifour G, et al
    Case Reports of Aripiprazole and Problematic Gambling in Schizophrenia: A Critical Review of the Evidence.
    J Clin Psychopharmacol. 2019 Jun 14. doi: 10.1097/JCP.0000000000001068.
    PubMed     Abstract available


  32. DEMARTINIS N 3RD, Lopez RN, Pickering EH, Schmidt CJ, et al
    A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia.
    J Clin Psychopharmacol. 2019 Jun 11. doi: 10.1097/JCP.0000000000001047.
    PubMed     Abstract available


  33. WU CS, Chen TY, Tsai SY, Chen CC, et al
    Estimating the Risk of Pneumonia in Patients With Schizophrenia Newly Receiving Clozapine: A Nationwide Cohort Study.
    J Clin Psychopharmacol. 2019 Jun 10. doi: 10.1097/JCP.0000000000001052.
    PubMed     Abstract available


  34. OZAWA C, Bies RR, Pillai N, Suzuki T, et al
    Model-Guided Antipsychotic Dose Reduction in Schizophrenia: A Pilot, Single-Blind Randomized Controlled Trial.
    J Clin Psychopharmacol. 2019 Jun 10. doi: 10.1097/JCP.0000000000001046.
    PubMed     Abstract available


    May 2019
  35. YANG N, Li S, Liu S, Lv Y, et al
    Insulin Resistance-Related Proteins Are Overexpressed in Patients and Rats Treated With Olanzapine and Are Reverted by Pueraria in the Rat Model.
    J Clin Psychopharmacol. 2019;39:214-219.
    PubMed     Abstract available


  36. SANTOS-CASADO M, Garcia-Avello A
    Systematic Review of Gender Bias in the Clinical Trials of New Long-Acting Antipsychotic Drugs.
    J Clin Psychopharmacol. 2019;39:264-272.
    PubMed     Abstract available


  37. CHOCHOL MD, Kataria L, O'Rourke MC, Lamotte G, et al
    Clozapine-Associated Myoclonus and Stuttering Secondary to Smoking Cessation and Drug Interaction: A Case Report.
    J Clin Psychopharmacol. 2019;39:275-277.
    PubMed    


    April 2019
  38. RICOUX O, Carton L, Menard O, Deheul S, et al
    Acute Psychosis Related to Baclofen in a Patient Treated for Binge Eating Disorder Highlights the Urgent Need to Regulate Off-label Prescriptions.
    J Clin Psychopharmacol. 2019 Apr 1. doi: 10.1097/JCP.0000000000001044.
    PubMed    


    March 2019
  39. PU ZP, Li GR, Zou ZP, Tao F, et al
    A Randomized, 8-Week Study of the Effects of Extended-Release Paliperidone and Olanzapine on Heart Rate Variability in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2019 Mar 28. doi: 10.1097/JCP.0000000000001023.
    PubMed     Abstract available


  40. BRUNO A, Pandolfo G, Crucitti M, Troili GM, et al
    Effect of Red Yeast Rice on Cognitive Functioning in Schizophrenia: Data From a Pilot Study.
    J Clin Psychopharmacol. 2019 Mar 27. doi: 10.1097/JCP.0000000000001025.
    PubMed     Abstract available


  41. KANE JM, Correll CU, Delva N, Gopal S, et al
    Low Incidence of Neuroleptic Malignant Syndrome Associated With Paliperidone Palmitate Long-Acting Injectable: A Database Report and Case Study.
    J Clin Psychopharmacol. 2019;39:180-182.
    PubMed    


  42. LEPPLA IE, Nucifora FC, Sedlak TW
    Extended Requirement of Granulocyte Colony-Stimulating Factor for Clozapine-Associated Neutropenia.
    J Clin Psychopharmacol. 2019;39:169-172.
    PubMed    


  43. WAGNER X, Kluge M
    Abrupt Decrease of Clozapine Plasma Concentration After Discontinuation of Flupentixol Comedication.
    J Clin Psychopharmacol. 2019;39:168-169.
    PubMed    


  44. DUSI N, Comacchio C, Lasalvia A
    Late-Onset Cholestatic Liver Injury During Combination Treatment With Chlorpromazine and Olanzapine: A Case Report.
    J Clin Psychopharmacol. 2019;39:175-176.
    PubMed    


    February 2019
  45. KUCUKGONCU S, Guloksuz S, Tek C
    Effects of Curcumin on Cognitive Functioning and Inflammatory State in Schizophrenia: A Double-Blind, Placebo-Controlled Pilot Trial.
    J Clin Psychopharmacol. 2019 Feb 8. doi: 10.1097/JCP.0000000000001012.
    PubMed    


    January 2019
  46. IVKOVIC J, Lindsten A, George V, Eriksson H, et al
    Effect of Brexpiprazole on Prolactin: An Analysis of Short- and Long-Term Studies in Schizophrenia.
    J Clin Psychopharmacol. 2019;39:13-19.
    PubMed     Abstract available


  47. SAGLAM AYKUT D
    Comparison of Paliperidone Palmitate and Second-Generation Oral Antipsychotics in Terms of Medication Adherence, Side Effects, and Quality of Life.
    J Clin Psychopharmacol. 2019;39:57-62.
    PubMed     Abstract available


    December 2018
  48. DIAS ALVES M, Micoulaud-Franchi JA, Simon N, Vion-Dury J, et al
    Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
    J Clin Psychopharmacol. 2018;38:555-562.
    PubMed     Abstract available


  49. MUDRA S, Luedecke D, Grafmann M, Schulte-Markwort M, et al
    Myocarditis During Treatment With Clozapine in 2 Adolescent Cases.
    J Clin Psychopharmacol. 2018;38:639-640.
    PubMed    


    October 2018
  50. SUZUKI H, Hibino H, Inoue Y, Takaya A, et al
    Treatment Continuation of 3 Second-Generation Antipsychotic Long-Acting Injections, and Oral Paliperidone in Patients With Schizophrenia for 2 Years.
    J Clin Psychopharmacol. 2018 Oct 16. doi: 10.1097/JCP.0000000000000976.
    PubMed    


  51. TANI H, Suzuki T, Wolfgang Fleischhacker W, Tomita M, et al
    Clinical Characteristics of Patients With Schizophrenia Who Successfully Discontinued Antipsychotics: A Literature Review.
    J Clin Psychopharmacol. 2018 Oct 8. doi: 10.1097/JCP.0000000000000959.
    PubMed     Abstract available


    September 2018
  52. KAKUNJE A, Prabhu A, Priya Es S, Karkal R, et al
    Acetazolamide for Antipsychotic-Associated Weight Gain in Schizophrenia.
    J Clin Psychopharmacol. 2018 Sep 6. doi: 10.1097/JCP.0000000000000940.
    PubMed    


    August 2018
  53. DIEFENDERFER LA, Lang SE, Patel M
    Successful Treatment of Delusional Disorder With Aripiprazole Long-Acting Injection.
    J Clin Psychopharmacol. 2018;38:400-402.
    PubMed    


  54. GONZALEZ-RODRIGUEZ A, Estrada F, Monreal JA, Palao D, et al
    A Systematic Review of Methods for the Measurement of Antipsychotic Adherence in Delusional Disorder.
    J Clin Psychopharmacol. 2018;38:412-414.
    PubMed    


    July 2018
  55. HARD ML, Wehr AY, Du Y, Weiden PJ, et al
    Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia.
    J Clin Psychopharmacol. 2018 Jul 13. doi: 10.1097/JCP.0000000000000921.
    PubMed     Abstract available


    June 2018
  56. KELLY DL, Powell MM, Wehring HJ, Sayer MA, et al
    Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women With Psychosis: Results From the DAAMSEL Clinical Trial.
    J Clin Psychopharmacol. 2018 Jun 15. doi: 10.1097/JCP.0000000000000898.
    PubMed     Abstract available


  57. ENGLISCH S, Jung HS, Eisenacher S, Lewien A, et al
    Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering From Comorbid Depression: Results From the AGOPSYCH Study.
    J Clin Psychopharmacol. 2018 Jun 14. doi: 10.1097/JCP.0000000000000909.
    PubMed     Abstract available


  58. BALLON JS, Ashfaq H, Noordsy DL
    Clozapine Titration for People in Early Psychosis: A Chart Review and Treatment Guideline.
    J Clin Psychopharmacol. 2018;38:234-238.
    PubMed     Abstract available


  59. SOLISMAA A, Kampman O, Lyytikainen LP, Seppala N, et al
    Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine.
    J Clin Psychopharmacol. 2018;38:193-199.
    PubMed     Abstract available


  60. HELLAND A, Habib S, Ulvestad L, Spigset O, et al
    Systemic Inflammation Complicates the Interpretation of Therapeutic Drug Monitoring of Risperidone.
    J Clin Psychopharmacol. 2018;38:263-265.
    PubMed    


    April 2018
  61. GAUDIANO BA, Guzman Holst C, Morena A, Reeves LE, et al
    Complex Polypharmacy in Patients With Schizophrenia-Spectrum Disorders Before a Psychiatric Hospitalization: Prescribing Patterns and Associated Clinical Features.
    J Clin Psychopharmacol. 2018 Apr 3. doi: 10.1097/JCP.0000000000000876.
    PubMed     Abstract available


  62. BOTILLO-MARTIN C, Gonzalez-Pablos E
    Rhabdomyolysis of Multifactorial Origin in Schizophrenia: Antipsychotics, Statins, Trauma.
    J Clin Psychopharmacol. 2018 Apr 2. doi: 10.1097/JCP.0000000000000880.
    PubMed    


  63. SAVULICH G, Mezquida G, Atkinson S, Bernardo M, et al
    A Case Study of Clozapine and Cognition: Friend or Foe?
    J Clin Psychopharmacol. 2018;38:152-153.
    PubMed    


    March 2018
  64. JONES C
    alpha7 Nicotinic Acetylcholine Receptor: A Potential Target in Treating Cognitive Decline in Schizophrenia.
    J Clin Psychopharmacol. 2018 Mar 2. doi: 10.1097/JCP.0000000000000859.
    PubMed     Abstract available


    February 2018
  65. HAJI SEYED JAVADI A, Shafikhani AA, Zamir SM, Khanshir ZF, et al
    Evaluation of the Effect of Fluvoxamine in Patients With Schizophrenia Under Risperidone Treatment: A Clinical Trial.
    J Clin Psychopharmacol. 2018 Feb 9. doi: 10.1097/JCP.0000000000000850.
    PubMed     Abstract available


  66. LIU F, Xie L, Zhang B, Ruan Y, et al
    No Effect of Adjunctive Minocycline Treatment on Body Metabolism in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2018 Feb 8. doi: 10.1097/JCP.0000000000000841.
    PubMed     Abstract available


  67. ZHAI D, Liu Y, Ma F, Feng Y, et al
    Effects of the First Exposure of Antipsychotics on Serum Albumin in Adolescents and Young Adults With First-Episode Schizophrenia.
    J Clin Psychopharmacol. 2018;38:103-105.
    PubMed    


  68. SAPRA M, Lawson D, Iranmanesh A
    Fat Distribution in Schizophrenia Patients: A Pilot Study Comparing First- and Second-Generation Antipsychotics.
    J Clin Psychopharmacol. 2018;38:68-71.
    PubMed     Abstract available


  69. ZHAO MJ, Qin B, Wang JB, Zhang YP, et al
    Efficacy and Acceptability of Cariprazine in Acute Exacerbation of Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials.
    J Clin Psychopharmacol. 2018;38:55-59.
    PubMed     Abstract available


  70. DYKEMA LR
    Abrupt Improvement in Obsessive-Compulsive Symptoms Upon Discontinuation of Clozapine.
    J Clin Psychopharmacol. 2018;38:88-89.
    PubMed    


    December 2017
  71. LIMOSIN F, Belhadi D, Comet D, Pacou M, et al
    Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France.
    J Clin Psychopharmacol. 2017 Dec 11. doi: 10.1097/JCP.0000000000000827.
    PubMed     Abstract available


  72. COLLE R, Boichot F, Bouteiller E, Elie-Lefebvre C, et al
    Restless Legs Syndrome and Schizophrenia: A Case Report.
    J Clin Psychopharmacol. 2017 Dec 6. doi: 10.1097/JCP.0000000000000832.
    PubMed    


    November 2017
  73. ALY EL-GABRY DM, Abdel Aziz K, Okasha T, Azzam H, et al
    Antipsychotic Polypharmacy and Its Relation to Metabolic Syndrome in Patients With Schizophrenia: An Egyptian Study.
    J Clin Psychopharmacol. 2017 Nov 28. doi: 10.1097/JCP.0000000000000815.
    PubMed     Abstract available


    October 2017
  74. SANDERS LLO, Menezes CES, Chaves Filho AJM, Viana GA, et al
    alpha-Lipoic Acid as Adjunctive Treatment for Schizophrenia: An Open-Label Trial.
    J Clin Psychopharmacol. 2017 Oct 19. doi: 10.1097/JCP.0000000000000800.
    PubMed     Abstract available


  75. JOY G, Whiskey E, Bolstridge M, Porras-Segovia A, et al
    Hearts and Minds: Real-Life Cardiotoxicity With Clozapine in Psychosis.
    J Clin Psychopharmacol. 2017 Oct 19. doi: 10.1097/JCP.0000000000000792.
    PubMed     Abstract available


  76. FEELEY RJ, Arnaout B, Yoon G
    Effective Switch From Clozapine to Aripiprazole in Treatment-Resistant Schizophrenia and Comorbid Alcohol Use Disorder.
    J Clin Psychopharmacol. 2017 Oct 12. doi: 10.1097/JCP.0000000000000794.
    PubMed    


  77. NAVKHARE P, Kalra G, Saddichha S
    Possible Psychosis Associated With Buprenorphine Withdrawal.
    J Clin Psychopharmacol. 2017 Oct 9. doi: 10.1097/JCP.0000000000000803.
    PubMed    


  78. ANG MS, Abdul Rashid NA, Lam M, Rapisarda A, et al
    The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia.
    J Clin Psychopharmacol. 2017 Oct 9. doi: 10.1097/JCP.0000000000000790.
    PubMed     Abstract available


  79. BERESFORD T, Buchanan J, Thumm EB, Emrick C, et al
    Late Reduction of Cocaine Cravings in a Randomized, Double-Blind Trial of Aripiprazole vs Perphenazine in Schizophrenia and Comorbid Cocaine Dependence.
    J Clin Psychopharmacol. 2017 Oct 3. doi: 10.1097/JCP.0000000000000789.
    PubMed     Abstract available


    September 2017
  80. SAJATOVIC M, Ramirez LF, Fuentes-Casiano E, Cage J, et al
    A 6-Month Prospective Trial of a Personalized Behavioral Intervention + Long-Acting Injectable Antipsychotic in Individuals With Schizophrenia at Risk of Treatment Nonadherence and Homelessness.
    J Clin Psychopharmacol. 2017 Sep 19. doi: 10.1097/JCP.0000000000000778.
    PubMed     Abstract available


  81. HOJLUND M, Munk-Jorgensen P
    Differences in Antipsychotic Prescriptions Between Centers in Young Outpatients With Schizophrenia.
    J Clin Psychopharmacol. 2017 Sep 7. doi: 10.1097/JCP.0000000000000779.
    PubMed    


    August 2017
  82. ZABALA A, Bustillo M, Querejeta I, Alonso M, et al
    A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients.
    J Clin Psychopharmacol. 2017 Aug 8. doi: 10.1097/JCP.0000000000000770.
    PubMed     Abstract available


    June 2017
  83. DOYLE R, Behan C, O'Keeffe D, Masterson S, et al
    Clozapine Use in a Cohort of First-Episode Psychosis.
    J Clin Psychopharmacol. 2017 Jun 23. doi: 10.1097/JCP.0000000000000734.
    PubMed     Abstract available


  84. SHE S, Yi W, Zhang B, Zheng Y, et al
    Worsening of Myasthenia Gravis After Administration of Antipsychotics for Treatment of Schizophrenia: A Case Report and Review of Literature.
    J Clin Psychopharmacol. 2017 Jun 20. doi: 10.1097/JCP.0000000000000741.
    PubMed    


  85. SHAO W, Brown T, Ayub S
    Phenelzine Withdrawal-Associated Psychosis and Mania.
    J Clin Psychopharmacol. 2017 Jun 13. doi: 10.1097/JCP.0000000000000739.
    PubMed    


  86. BRUNO A, Pandolfo G, Crucitti M, Cedro C, et al
    Bergamot Polyphenolic Fraction Supplementation Improves Cognitive Functioning in Schizophrenia: Data From an 8-Week, Open-Label Pilot Study.
    J Clin Psychopharmacol. 2017 Jun 6. doi: 10.1097/JCP.0000000000000730.
    PubMed     Abstract available


  87. BARMAN R, Kumar S, Pagadala B, Detweiler MB, et al
    Cocaine Abuse, Traumatic Brain Injury, and Preexisting Brain Lesions as Risk Factors for Bupropion-Associated Psychosis.
    J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000729.
    PubMed     Abstract available


  88. WATANABE J, Fukui N, Suzuki Y, Sugai T, et al
    Effect of GWAS-Identified Genetic Variants on Maximum QT Interval in Patients With Schizophrenia Receiving Antipsychotic Agents: A 24-Hour Holter ECG Study.
    J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000724.
    PubMed     Abstract available


  89. KANTROWITZ JT, Nolan KA, Epstein ML, Lehrfeld N, et al
    Neurophysiological Effects of Bitopertin in Schizophrenia.
    J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000722.
    PubMed     Abstract available


  90. BUCHANAN RW, Kelly DL, Weiner E, Gold JM, et al
    A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.
    J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000720.
    PubMed     Abstract available


  91. ZHENG W, Wang S, Ungvari GS, Ng CH, et al
    Amantadine for Antipsychotic-Related Weight Gain: Meta-Analysis of Randomized Placebo-Controlled Trials.
    J Clin Psychopharmacol. 2017;37:341-346.
    PubMed     Abstract available


  92. LOPEZ LV, Shaikh A, Merson J, Greenberg J, et al
    Accuracy of Clinician Assessments of Medication Status in the Emergency Setting: A Comparison of Clinician Assessment of Antipsychotic Usage and Plasma Level Determination.
    J Clin Psychopharmacol. 2017;37:310-314.
    PubMed     Abstract available


    April 2017
  93. ISMAIL Z, Peters-Strickland T, Miguelez M, Baker RA, et al
    Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores.
    J Clin Psychopharmacol. 2017 Apr 5. doi: 10.1097/JCP.0000000000000710.
    PubMed     Abstract available


  94. KOHLER-FORSBERG O, Horsdal HT, Legge SE, MacCabe JH, et al
    Predictors of Nonhospitalization and Functional Response in Clozapine Treatment: A Nationwide, Population-Based Cohort Study.
    J Clin Psychopharmacol. 2017;37:148-154.
    PubMed     Abstract available


    March 2017
  95. HARD ML, Mills RJ, Sadler BM, Turncliff RZ, et al
    Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia.
    J Clin Psychopharmacol. 2017 Mar 27. doi: 10.1097/JCP.0000000000000691.
    PubMed     Abstract available


  96. GAHR M, Hiemke C, Connemann BJ, Schonfeldt-Lecuona C, et al
    First-Episode Psychosis Possibly due to Roxithromycin-Related Inhibition of Metabolization of Tetrahydrocannabinol.
    J Clin Psychopharmacol. 2017 Mar 21. doi: 10.1097/JCP.0000000000000707.
    PubMed    


  97. LIN CH, Lane HY
    Clotiapine Monotherapy in a Patient With Clozapine-Resistant Schizophrenia.
    J Clin Psychopharmacol. 2017 Mar 21. doi: 10.1097/JCP.0000000000000692.
    PubMed    


    February 2017
  98. LOOK ML, Boo YL, Chin PW, Hoo FK, et al
    Risperidone-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome: A Case Report.
    J Clin Psychopharmacol. 2017;37:105-106.
    PubMed    


  99. GOTO T, Kato M, Matsumura Y, Omata N, et al
    Scopolamine Ointment for Clozapine-Associated Sialorrhea: A Case Report.
    J Clin Psychopharmacol. 2017;37:106-107.
    PubMed    


    October 2016
  100. STRUBE W, Kirsch B, Padberg F, Hasan A, et al
    Transcranial Direct Current Stimulation as Monotherapy for the Treatment of Auditory Hallucinations During Pregnancy: A Case Report.
    J Clin Psychopharmacol. 2016;36:534-5.
    PubMed    


  101. BUZINA N, Eterovic M
    Life-Threatening Lupus-Like Syndrome Associated With Clozapine.
    J Clin Psychopharmacol. 2016;36:532-4.
    PubMed    


  102. JAKOBSEN KD, Bruhn CH, Pagsberg AK, Fink-Jensen A, et al
    Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
    J Clin Psychopharmacol. 2016;36:496-9.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: